WuXi PharmaTech Healthcare Fund I L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Adagene Inc. Ordinary shares, par value US$0.0001 per share (ADAG)

Filing Manager: WuXi PharmaTech Healthcare Fund I L.P.
Reporting Manager: WuXi PharmaTech Healthcare Fund I L.P.
Security: Adagene Inc. Ordinary shares, par value US$0.0001 per share
Symbol: ADAG
Shares outstanding: 58.9M shares
Disclosed Ownership: 4.12M shares
Ownership: 7%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 17:42:29
Date of event: 30 Sep 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
WuXi PharmaTech Healthcare Fund I L.P.	7%	4.12M	0	4.12M	/s/ Ming Shi	Ming Shi, Director
WuXi AppTec Co., Ltd.	7%	4.12M	0	4.12M	/s/ Ming Shi	Ming Shi, Director